Advertisement

Topics

FDA grants orphan status to Curtana's glioblastoma, tumor drug

04:42 EDT 21 Aug 2017 | SmartBrief

The FDA granted orphan drug status to Curtana Pharmaceuticals' CT-179, intended for the treatment of brain tumors in children -More

Original Article: FDA grants orphan status to Curtana's glioblastoma, tumor drug

NEXT ARTICLE

More From BioPortfolio on "FDA grants orphan status to Curtana's glioblastoma, tumor drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...